Abstract:Objective To compare the efficacy and safety of isophane insulin injection 30R and isophane protamine biosynthetic human insulin injection 30R in patients with type 2 diabetes mellitus poorly controlled with oral hypoglycemic agents.Methods One hundred and forty patients with type 2 diabetes mellitus poorly controlled with oral hypoglycemic agents from June,2009 to June,2010 were divided randomly in a ratio of 1:1 into group A and group B.There was no differences in age,gender,height,weight between the two groups.The group A and group B were given isophane protamine insulin injection 30R and isophane protamine biosynthetic human insulin injection 30R respectively.All the patients were injected insulin before breakfast and supper together with previous oral agents for 12 weeks.Insulin dosage was determined and adjusted according to blood glucose.At the end of the 12 week,the two groups exchanged the insulins and continued the therapy for another 12 weeks.The glycated hemoglobin Alc (HbAlc),fasting blood glucose(FBG),2 h postprandial blood glucose (PBG) and insulin autoantibody (IAA) were investigated at the end of the treatments.Paired t test and Wilcoxon test were used in the data analysis.Results After 12 weeks,there were no significant differences in HbAlc ((7.7 ± 1.3 )％ vs (7.5 ±0.9)％,t=1.24,P＞0.05),FBG((8.0±2.0) vs (7.4±1.6)mmol/L,t=1.05,P＞0.05) and PBG ( ( 13 ± 4) vs ( 12 ± 4) mmol/L,t =0.90,P ＞ 0.05 ) in group A and group B.After 24 weeks,no significant differences in the above-mentioned indexes was found between the two groups either:HbAlc ((8.3±1.5)％ vs (7.5 ±1.0)％,x2 =0.01,P＞0.05),FBG ((7.8±2.0) vs (7.9±2.1) mmol/L,x2=0.04,P＞0.05) andPBG ((12±4) vs (12±4)mmoL/L,x2=0.82,P＞0.05).The levels of IAA were comparable between the two groups at the end of the 12th week ( ( 19 ± 12) vs ( 19 ± 13) mU/L,t =0.11,P＞0.05) and at the end of the 24th week ((19 ±11) vs (18 ±12) mU/L,x2 =1.26,P＞0.05).The incidence of hypoglycemia in group A was 16.4％ before insulin-exchanging and 6.4％ after,and that was 15.0％ and 2.9％ in Group B.No hypersensitivity reaction in local skin,lipoatrophy or subcutaneous nodule occurred during the investigation.Conclusion The results suggest that isophane insulin injection 30R has the same efficacy and safety as isophane protamine biosynthetic human insulin injection 30R.

Therapeutic Comparison on Insulia Aspart 30 and Novolin 30R in the Treatment of Type Two Diabetes Mellitus after Failure to Oral Hypoglycemic Agents

Clinical Observation on Starting Insulin after Failure of Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus

[The Comparison of Insulin Aspart and Human Soluble Insulin Used in Insulin Pump Therapy in Newly Diagnosed Type 2 Diabetic Patients].

Comparison of efficacy and safety of Gansulin 30R and Novolin 30R in the treatment of type 2 diabetic patients: a multicenter randomized open controlled clinical trial

Comparison of therapeutic efficacy between Aspart and regular human insulin delivered by insulin pump

Clinical Comparison of Basal Insulin and Premixed Insulin in the Treatment of Type 2 Diabetes Mellitus

Comparison between the effects of insulin Aspart and Novolin R via continuous subcutaneous insulin infusion pump on hyperglycemia in elderly patients with type 2 diabetes

A 2-Way Cross-Over, Open-Labeled Trial to Compare Efficacy and Safety of Insulin Aspart and Novolin R Delivered with CSII in 21 Chinese Diabetic Patients

Dosage of Insulin Treatment on Newly Diagnosed Type 2 Diabetics

Comparison of the Effect Between Insulin Lispro 75/25 and Humulin 70/30 on the Postprandial Blood Glucose Excursion in Patients with Diabetes

Efficacy and Safety of Isophane Protamine Insulin Injection 30R to Isophane Protamine Biosynthetic Human Insulin Injection 30R in Type 2 Diabetics Poorly Controlled with Oral Hypoglycemic Agents

Comparison of the efficacy between short term intensive therapy by insulin pump and multiple subcutaneous insulin injections

Efficacy and Safety of Additional Basal Insulin or Oral Antidiabetic Drug in Type 2 Diabetes Poorly Controlled with One Oral Antidiabetic Drug

Observation of curative effect on Insulin Aspartate in the treatment of newly diagnosed type 2 diabetes mellitus

Efficacy and Safety of Insulin Detemir Plus Insulin Aspart Versus NPH Insulin Plus Human Soluble Insulin with or Without Metformin in Chinese Type 2 Diabetes

Efficacy and safety of biphasic insulin aspart 30 in the treatment of diabetic patients: a multicenter, randomized, open-labeled controlled trial

[Comparison of efficacy and safety of insulin aspart injection Rishulin and NovoRapid for treatment of diabetes: a multicenter, randomized, open-labeled, controlled trial].

Meta-analysis of insulin aspart versus regular human insulin in diabetes treatment in China

The Effect of Insulin Aspart on the Metabolic Changes of Children with Type 1 Diabetes

Comparative Efficacy and Safety of Glucose-Lowering Drugs as Monotherapy for Type 2 Diabetes: A Systematic Review and Indirect Treatment Comparison

Comparison of the effect of different short-term intensive anti-diabetic therapies on newly diagnosed type 2 diabetic patients.